Affinity Asset Advisors, LLC Point Biopharma Global Inc. Transaction History

Affinity Asset Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.78 - $8.1 $1.04 Million - $1.24 Million	-153,632 Reduced 50.67%	149,586 $1.09 Million
Q4 2022 Feb 13, 2023	SELL	$5.72 - $9.78 $2.54 Million - $4.34 Million	-443,358 Reduced 59.39%	303,218 $2.21 Million
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $5.22 Million - $7.43 Million	720,998 Added 2818.82%	746,576 $5.77 Million
Q2 2022 Aug 12, 2022	BUY	$5.6 - $9.5 $143,236 - $242,991	25,578 New	25,578 $174,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.